Top Biotechnology companies in Europe by EBIT

This ranking features the top 260 Biotechnology companies in Europe ranked by EBIT, totaling a EBIT of USD 89.16 B, for June 22, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 5 6

Frequently Asked Questions

Which Biotechnology company in Europe has the highest EBIT ?

The Biotechnology company in Europe with the highest EBIT is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 17.87 B.
Which Biotechnology company in Europe has the lowest EBIT ?

The Biotechnology company in Europe with the lowest EBIT is Atai Life Sciences N.V. (NasdaqGM: ATAI) at None.

What are the top 10 Biotechnology companies in Europe by EBIT ?

The top 10 Biotechnology companies in Europe by EBIT are Novo Nordisk A/S, Novartis AG, Roche Holding AG, AstraZeneca PLC, Sanofi, GSK plc, Bayer AG, MERCK Kommanditgesellschaft auf Aktien, Siemens Healthineers AG and UCB SA.
What are the bottom 10 Biotechnology companies in Europe by EBIT ?

The bottom 10 Biotechnology companies in Europe by EBIT are Atai Life Sciences N.V., Aptorum Group Limited, Advicenne S.A., Affluent Medical SA, Akari Therapeutics, Plc, genOway SA, Biosynex SA, Adocia SA, 2cureX AB (publ) and Cizzle Biotechnology Holdings Plc.